Nucleoside-mediated mitigation of 5-fluorouracil-induced toxicity in synchronized murine erythroleukemic cells

Toxicology and Applied Pharmacology

Volumn 146, Issue 1, 1997, Pages 29-39

  Elstein, Kenneth H ^a   Mole, M Leonard ^a   Setzer, R Woodrow ^a   Zucker, Robert M ^a   Kavlock, Robert J ^a   Rogers, John M ^a   Lau, Christopher ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYADENOSINE TRIPHOSPHATE; DEOXYGUANOSINE TRIPHOSPHATE; DEOXYRIBONUCLEOTIDE; FLUOROURACIL; NUCLEOSIDE; THYMIDINE; THYMIDINE TRIPHOSPHATE;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; EMBRYO; ERYTHROLEUKEMIA CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MOUSE; NONHUMAN; RAT;

ANIMALIA; MURINAE;

EID: 0030963723     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1997.8208     Document Type: Article

References (49)

1. Abbott B. D., Lau C., Buckalew A. R., Logsdon T. R., Setzer W., Zucker R. M., Elstein K. H., Kavlock R. J. Effects of 5-fluorouracil on embryonic rat palate in vitro: Fusion in the absence of proliferation. Teratology. 47:1993;541-554.
2. Boike G. M., Deppe G., Young J. D., Malone J. M., Malviya V. K., Sokol R. J. Chemotherapy in a pregnant rat model: 2. 5-Fluorouracil: Nonlinear kinetics and placental transfer. Gynecol. Oncol. 34:1989;191-194.
3. Chaube S., Murphy M. L. Protective effect of deoxycytidylic acid (CdMP) on hydroxyurea-induced malformations in rats. Teratology. 7:1973;79-88.
4. Crissman H. A., Darzynkiewicz Z., Tobey R. A., Steinkamp J. A. Normal and perturbed Chinese hamster ovary cells: Correlation of DNA, RNA, and protein content by flow cytometry. J. Cell. Biol. 101:1985;141-147.
5. Dagg C. P., Kallio E. Teratogenic interaction of fluorodeoxyuridine and thymidine. Anat. Rec. 142:1962;301-302.
6. Darzynkiewicz Z., Bruno S., Del Bino G., Gorczyca W., Hotz M. A., Lassota P., Traganos F. Features of apoptotic cells measured by flow cytometry. Cytometry. 13:1992;795-808.
7. Dean P. N., Jett J. H. Mathematical analysis of DNA distributions derived from flow cytometry. J. Cell. Biol. 60:1974;523-527.
8. Elstein K. H., Zucker R. M., Andrews J. E., Ebron-McCoy M., Shuey D. L., Rogers J. M. Effects of developmental stage and tissue type on embryo/fetal DNA distributions and 5-fluorouracil-induced cell-cycle perturbations. Teratology. 48:1993a;355-363.
9. Elstein K. H., Zucker R. M., Shuey D. L., Lau C., Chernoff N., Rogers J. M. Utility of the murine erythroleukemic cell (MELC) in assessing mechanisms of action of DNA-active developmental toxicants: Application to 5-fluorouracil. Teratology. 48:1993b;75-87.
10. Eriksson S., Gräslund A., Skog S., Thelander L., Tribukait B. Cell cycle-dependent regulation of mammalian ribonucleotide reductase. J. Biol. Chem. 259:1984;11695-11700.
11. Forsthoefel P. F., Williams M. L. The effects of 5-fluorouracil and 5-fluorodeoxyuridine used alone and in combination with normal nucleic acid precursors on development of mice in lines selected for low and high expression of Strong's luxoid gene. Teratology. 11:1974;1-20.
12. Garrett C., Santi D. V. A rapid and sensitive high pressure liquid chromatography assay for deoxyribonucleoside triphosphates in cell extracts. Anal. Biochem. 99:1979;268-273.
13. Hansen D. K., Grafton T. F. Attenuation of 5-fluorouracil-induced embryotoxicity by exogenous thymidine in vitro. In Vitro Toxicol. 2:1989;249-258.
14. Hansen D. K., Grafton T. F., Cross D. R., James S. J. Partial attenuation of hydroxyurea-induced embryotoxicity by deoxyribonucleotides in mouse and rat embryos treated in vitro. Toxic. in Vitro. 9:1995;11-19.
15. Harmenberg J., Karlsson A. H. J., Gilljam G. Comparison of sample preparation methods for the high-performance liquid chromatographic analysis of cell culture extracts for triphosphate ribonucleosides and deoxyribonucleosides. Anal. Biochem. 161:1987;26-31.
16. Jackson R. C. The regulation of thymidylate biosythesis in Novikoff hepatoma cells and the effects of amethopterin, 5-fluorudeoxyuridine, and 3-deazauridine. J. Biol. Chem. 253:1978;7440-7446.
17. Jackson R. C. The biochemical basis of anti-cancer drug selectivity: A detailed model of pyrimidine metabolism. The Theoretical Foundation of Cancer Chemotherapy Introduced by Computer Models. 1992;Academic Press, New York. p. 337-.
18. Kauffman M. G., Noga S. J., Kelly T. J., Donnenberg A. D. Isolation of cell cycle fractions by counterflow centrifugal elutriation. Anal. Biochem. 191:1990;41-46.
19. Kavlock R. J., Setzer R. W. The road to embryologically based dose-response models. Environ. Health Perspect. 104:1996;107-121.
20. Klohs W. D., Kraker A. J. Pentostatin: Future directions. Pharm. Rev. 44:1992;459-477.
21. Koury M. J., Horne D. W. Apoptosis mediates and thymidine prevents erythroblast destruction in folate deficiency anemia. Proc. Natl. Acad. Sci. USA. 91:1994;4067-4071.
22. Kyprianou N., Isaacs J. T. "Thymineless" death in androgen-independent prostatic cancer cells. Biochem. Biophys. Res. Commun. 165:1989;73-81.
23. Maley F., Maley G. F. Mechanisms of enzyme modulation involving deoxycytidylate deaminase and thymidylate synthetase. Adv. Enzyme Regul. 8:1970;55-71.
24. Meuth M. The genetic consequences of nucleotide precursor pool imbalance in mammalian cells. Mutat. Res. 126:1984;107-112.
25. M. L. Mole, D. L. Hunter, P. Gao, C. Lau, 1997, Sample Preparation and High Performance Liquid Chromatographic Analysis of Deoxyribonucleoside Triphosphates in Individual Rat Embryos.
26. Myers C. E., Young R. C., Chabner B. A. Biochemical determinants of 5-fluorouracil response in vivo: The role of deoxyuridylate pool expansion. J. Clin. Invest. 56:1975;1231-1238.
27. Nicander B., Reichard P. Relations between synthesis of deoxyribonucleotides and DNA replication in 3T6 fibroblasts. J. Biol. Chem. 260:1985;5376-5381.
28. O'Dwyer P. J., King S. A., Hoth D. F., Leyland-Jones B. Role of thymidine in biochemical modulation: A review. Cancer Res. 47:1987;3911-3919.
29. Parker W. B., Cheng Y. C. Metabolism and mechanism of action of 5-fluorouracil. Pharmacol. Ther. 48:1990;381-395.
30. Pinendo H. M., Peters G. F. J. Fluorouracil: Biochemistry and pharmacology. J. Clin. Oncol. 6:1988;1653-1664.
31. Ritter E. J., Scott W. J., Wilson J. G., Lampkin B. C., Neely J. E. Effect of 5-fluoro-2′-deoxyuridine on deoxyribonucleotide pools in vivo. J. Natl. Cancer Inst. 65:1980;603-605.
32. Schuetz J. D., Wallace H. J., Diasio R. B. 5-Flurouracil incorporation into DNA of CF-1 mouse bone marrow cells as a possible mechanism of toxicity. Cancer Res. 44:1984;1358-1363.
33. Schumacher H. J., Wilson J. G., Jordan R. L. Potentiation of the teratogenic effects of 5-fluorouracil by natural pyrimidines. I. Biochemical aspects. Teratology. 2:1969;99-106.
34. Shuey D. L., Lau C., Logsdon T. R., Zucker R. M., Elstein K. H., Narotsky M. G., Setzer R. W., Kavlock R. J., Rogers J. M. Biologically based dose-response modeling in developmental toxicology: Biochemical and cellular sequelae of 5-fluorouracil exposure in the developing rat. Toxicol. Appl. Pharmacol. 126:1994;129-144.
35. Skoog L., Nordenskjöld B. Effects of hydroxyurea and 1-β-D-arabinofuarnosyl-cytosine on deoxyribonucleotide pools in mouse embryo cells. Eur. J. Biochem. 19:1971;81-89.
36. Tanaka K., Yoshioka A., Tanaka S., Wataya Y. An improved method for the quantitative determination of deoxyribonucleoside triphosphates in cell extracts. Anal. Biochem. 139:1984;35-41.
37. Tattersall M. H. N., Harrap K. R. Changes in the deoxynucleoside triphosphate pools of mouse 5178Y lymphoma cells following exposure to methotrexate or 5-fluorouracil. Cancer Res. 33:1973;3086-3090.
38. Tsukamoto I., Kojo S. The effects of fluorouracil on thymidylate synthase and thymidine kinase in regenerating rat liver after partial hepatectomy. Biochim. Biophys. Acta. 1074:1991;52-55.
39. Tukey J., Ciminera J., Heyse B. Testing the statistical certainty of a response to increasing dose of a drug. Biometrics. 41:1985;295-301.
40. Valeriote F., Santinelli G. 5-Fluorouracil (FUra). Pharmacol. Ther. 24:1984;107-132.
41. Washtien W. L. Increased levels of thymidylate synthetase in cells exposed to 5-fluorouracil. Mol. Pharmacol. 25:1984;171-177.
42. Wilson J. G., Jordan R. L., Schumacher H. Potentiation of the teratogenic effects of 5-fluorouracil by natural pyrimidines. I. Biological aspects. Teratology. 2:1969;91-98.
43. Xeros N. Deoxyriboside control and synchronization of mitosis. Nature. 194:1962;682-683.
44. Yoshioka A., Tanaka S., Hiraoka O., Koyama Y., Hirota Y., Ayusawa D., Seno T., Garrett C., Wataya Y. Deoxyribonucleoside triphosphate imbalance: 5-Fluorodeoxyuridine-induced DNA double strand breaks in mouse FM3A cells and the mechanism of cell death. J. Biol. Chem. 262:1987;8235-8241.
45. Zucker R. M., D'Alisa R. M., Gershey E. L. Characterization of a CV-1 cell cycle: III. Biophysical parameters. Exp. Cell Res. 122:1979a;1-8.
46. Zucker R. M., Wu N. C., Krishan A., Silverman M. Synchronization of murine erythroleukemic cells: Nuclear volume measurements for monitoring cell cycle traverse. Exp. Cell Res. 123:1979b;383-387.
47. Zucker R. M., Elstein K. H., Easterling R. E., Massaro E. J. Flow cytometric discrimination of mitotic nuclei by right-angle light scatter. Cytometry. 9:1988a;226-231.
48. Zucker R. M., Elstein K. H., Easterling R. E., Ting-Beall H. P., Allis J. W., Massaro E. J. Effects of tributyltin on biomembranes: Alteration of flow cytometric parameters and inhibition of Na+, K+-ATPase two-dimensional crystallization. Toxicol. Appl. Pharmacol. 96:1988b;393-403.
49. Zucker R. M., Elstein K. H., Thomas D. J., Rogers J. M. Tributyltin and dexamethasone induce apoptosis in rat thymocytes by mutually antagonistic mechanisms. Toxicol. Appl. Pharmacol. 127:1994;163-170.